Same-day test helps doctors detect hidden infections in critically ill children

Metagenomic testing at Great Ormond Street Hospital identifies drug-resistant bacteria standard tests miss

By LineZotpaper
Published
Read Time2 min
A pioneering same-day test has helped doctors detect hidden and drug-resistant infections in more than 100 critically ill children in intensive care at London's Great Ormond Street Hospital (GOSH), the BBC reports. The technique, known as metagenomic testing, has influenced prescribing decisions and, in one case described in the report, proved lifesaving.

Respiratory samples from more than 100 critically ill young patients at Great Ormond Street Hospital were sent for metagenomic testing, a technique that sequences all genetic material present in a single sample to identify bacteria, viruses and fungi at once. It contrasts with conventional methods, where clinicians must decide in advance what they are looking for.

In many cases the results influenced what doctors prescribed. The BBC reports that metagenomics can detect infections that standard tests miss, meaning better outcomes for some critically ill patients.

The report highlights the case of 10-year-old Willow Crowther from Kent, who became dangerously ill with pneumonia in March. The illness triggered a seizure and multiple cardiac arrests, and she was admitted to intensive care. Her mother, Stacey Moore, was told Willow had a 50 per cent chance of survival.

"The consultant said... we should bring our family up to say goodbye to her. This is how critical and in how much danger she was of passing away," Moore told the BBC.

The test identified that Willow had a drug-resistant bacterial infection which needed a different antibiotic to the one she had been prescribed. "The fact that they had a test there available to her was paramount. It saved her life," Moore said.

§

Analysis

Why This Matters

  • For critically ill children, hours can determine outcomes. A same-day result can steer antibiotic choice before an infection overwhelms the patient.
  • The test detects drug-resistant bacteria that standard tests miss, making it directly relevant to the growing global problem of antimicrobial resistance.
  • If the approach becomes routine, it could shift prescribing from broad-spectrum antibiotics toward drugs matched to the actual pathogen.

Background

Metagenomic testing is an emerging diagnostic technique that sequences all genetic material in a sample, rather than testing for a known list of suspected pathogens. It has attracted particular interest in intensive care, where patients are vulnerable to fast-moving and unexpected infections. The work at Great Ormond Street is part of a wider push to bring the technology into NHS use, with a dedicated NHS metagenomics program referenced in the report.

Key Perspectives

Great Ormond Street clinicians: The hospital is using the test to guide treatment, with results influencing what doctors prescribe in many cases and catching infections conventional methods miss. Patients' families: Stacey Moore credits the test with saving her daughter's life, describing its availability at the hospital as paramount. Skeptics and open questions: The report contains no criticism of the approach, but broader adoption will likely depend on cost, turnaround time and evidence that the test improves outcomes across large numbers of patients, not only in individual cases.

What to Watch

  • Whether metagenomic testing expands beyond Great Ormond Street to other NHS hospitals and patient groups.
  • Published outcome data from the program as more respiratory samples are processed.
  • Whether the technique is trialled on sample types beyond respiratory samples, such as blood.

Sources

Zotpaper

Written by software from the reporting listed above, scored by an automated standards desk, and published without a person reading it first. If something here is wrong, tell the editor and it will be put right.

How we workSubscribe